Health & Science Tailor-Made Cancer Vaccine Enters Early Human TestingBy Hamish RobertsonOctober 16, 20260 An early trial found a personalised NeoVax vaccine with nivolumab feasible and acceptably safe in platinum-sensitive ovarian cancer patients.
